Skip to main content
. 2022 Oct 12;118(2):317–326. doi: 10.1111/add.16056

TABLE 1.

Pregnancies during the COVID‐19 pandemic, Kaiser Permanente Northern California

Characteristic Cannabis use status at start of follow‐up a
All (n = 58 114) Current (n = 4053) Recently quit (n = 7002) Non‐user (n = 47 059)
Age group, n (%) b , c , d
< 25 years 6447 (11.09) 1347 (33.23) 1139 (16.27) 3961 (8.42)
25–< 35 years 36 742 (63.22) 2152 (53.10) 4402 (62.87) 30 188 (64.15)
35+ years 14 925 (25.68) 554 (13.67) 1461 (20.87) 12 910 (27.43)
Age, mean (median) b , c , d 31.08 (31.00) 27.69 (27.00) 30.18 (31.00) 31.50 (32.00)
Race/ethnicity, n (%) b , c , d
Asian or Pacific Islander 15 317 (26.36) 233 (5.75) 1136 (16.22) 13 948 (29.64)
Black 3536 (6.08) 925 (22.82) 525 (7.50) 2086 (4.43)
Hispanic 15 528 (26.72) 1234 (30.45) 1796 (25.65) 12 498 (26.56)
Other/unknown/multi‐racial 3509 (6.04) 291 (7.18) 506 (7.23) 2712 (5.76)
White 20 224 (34.80) 1370 (33.80) 3039 (43.40) 15 815 (33.61)
Neighborhood deprivation, n (%) b , c
Quartile 1, least deprived 13 201 (22.72) 390 (9.62) 1670 (23.85) 11 141 (23.67)
Quartile 2 14 461 (24.88) 756 (18.65) 1775 (25.35) 11 930 (25.35)
Quartile 3 14 027 (24.14) 1075 (26.52) 1660 (23.71) 11 292 (24.00)
Quartile 4, most deprived 16 344 (28.12) 1820 (44.91) 1881 (26.86) 12 643 (26.87)
Missing 81 (0.14) 12 (0.30) 16 (0.23) 53 (0.11)
Subsidized insurance—Medicare, Medicaid or other, n (%) b , c , d 6016 (10.35) 1033 (25.49) 718 (10.25) 4265 (9.06)
Body mass index, n (%) b , c , d
Underweight 1355 (2.33) 104 (2.57) 136 (1.94) 1115 (2.37)
Normal 23 070 (39.70) 1142 (28.18) 2861 (40.86) 19 067 (40.52)
Overweight 16 154 (27.80) 1035 (25.54) 1910 (27.28) 13 209 (28.07)
Obese 15 738 (27.08) 1651 (40.74) 1905 (27.21) 12 182 (25.89)
Unknown 1797 (3.09) 121 (2.99) 190 (2.71) 1486 (3.16)
Pre‐existing diabetes, n (%) e 1080 (1.86) 75 (1.85) 107 (1.53) 898 (1.91)
Pre‐existing hypertension, n (%) b , c , e 4061 (6.99) 412 (10.17) 513 (7.33) 3136 (6.66)
Parity, n (%) b , c , d
0 23 027 (39.62) 1770 (43.67) 4203 (60.03) 17 054 (36.24)
1 20 803 (35.80) 1204 (29.71) 1554 (22.19) 18 045 (38.35)
2 7959 (13.70) 506 (12.48) 578 (8.25) 6875 (14.61)
3 2546 (4.38) 205 (5.06) 131 (1.87) 2210 (4.70)
4+ 1247 (2.15) 75 (1.85) 48 (0.69) 1124 (2.39)
Tobacco smoking status at start of follow‐up, n (%) a , b , c , d
Current 1503 (2.59) 522 (12.88) 294 (4.20) 687 (1.46)
Former 6761 (11.63) 1094 (26.99) 1244 (17.77) 4423 (9.40)
Unknown 7 (0.01) 0 (0.00) 1 (0.01) 6 (0.01)
Never 49 843 (85.77) 2437 (60.13) 5463 (78.02) 41 943 (89.13)

The COVID‐19 pandemic was considered to have begun on 5 March 2020. Pregnancies were included if they began prior to 1 December 2020 and ended between 5 March 2020 and 30 September 2021.

a

Follow‐up began at the earliest of pregnancy onset or 5 March 2020. In statistical models, cannabis use and tobacco smoking status were treated as time‐changing variables during the course of the pregnancy.

b

Differences between people whose cannabis use status at start of follow‐up was ‘current’ and people whose cannabis use status was ‘recently quit’ were significant at P < 0.01.

c

Differences between people whose cannabis use status at start of follow‐up was ‘current’ and people whose cannabis use status was ‘non‐user’ were significant at P < 0.01.

d

Differences between people whose cannabis use status at start of follow‐up was ‘recently quit’ and people whose cannabis use status was ‘non‐user’ were significant at P < 0.01.

e

Differences between people whose cannabis use status at start of follow‐up was ‘recently quit’ and people whose cannabis use status was ‘non‐user’ were significant at P < 0.05.